Martin Kampmann receives New Innovator Award from NIH's High-Risk, High-Reward research program
The National Institutes of Health (NIH) announced a New Innovator Award for Dr. Martin Kampmann, Assistant Professor in the Department of Biochemistry and Biophysics and the Institute for Neurodegenerative Diseases. This $1.5 million award is part of the High-Risk, High-Reward research program established by the NIH to support exceptionally innovative biomedical research.
The Kampmann lab investigates how pathways maintaining the integrity of cellular proteins, termed the proteostasis network, are rewired and challenged in disease. Neurodegenerative diseases in which proteins misfold and aggregate, including Alzheimer’s disease and Parkinson’s disease, are a major focus. The Kampmann lab uses an interdisciplinary approach that integrates CRISPR-based functional genomics with biochemistry and cell biology to understand disease mechanisms and pinpoint therapeutic strategies.